Abbott's XIENCE PRIME stent wins FDA approval

11/2/2011 | Reuters

The FDA has granted Abbott Laboratories approval for its XIENCE PRIME everolimus-eluting stent for use in treating patients with coronary artery disease. The device has an improved design that allows more flexibility and accuracy in stent delivery and placement.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR